To conclude, our present study hereby demonstrates that oral LP45 administration could significantly prevent pathologically enhanced bone resorption in GIO rats, suggesting its potential as a dietary supplement with beneficial effects against osteoporosis, which might involve the RANKL/OPG signaling pathway. The gene discussed is TNFRSF11B; the disease is osteoporosis.